Key points
- Noveltreat is semaglutide, made by Sun Pharma, approved in India for chronic weight management.
- It comes as a pre-filled pen in five strengths, 0.25 mg to 2.4 mg.
- At launch it cost about ₹900 to ₹2,000 a week, depending on the dose.
- Sun's other semaglutide brand, Sematrinity, is for type 2 diabetes.
What Noveltreat is
Noveltreat is a once-weekly semaglutide injection from Sun Pharma, launched in India on 22 March 2026. It is approved for chronic weight management in adults, alongside a reduced-calorie diet and more physical activity: the same use as Wegovy.
It comes as a pre-filled pen with a concealed needle, in five strengths that follow the standard semaglutide schedule: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg. Sun Pharma also sells Sematrinity, a semaglutide pen for type 2 diabetes in 2 mg and 4 mg multi-dose pens. The two brands are licensed for different uses.
Noveltreat price in India
At launch, Sun Pharma priced Noveltreat at about ₹900 a week at the starting dose, rising to about ₹2,000 a week at the highest dose: roughly ₹3,600 to ₹8,000 a month. Generic semaglutide prices have moved quickly since March 2026, so check the current MRP on the pack.
* Prices are manufacturers' maximum retail prices (MRP) in India, checked October 2026, and are shown as a guide only. Prices change often and may differ when you buy. Lean Life does not sell medicines online: any medicine is prescribed only after a consultation with a Lean Life doctor, and dispensed by a licensed pharmacy.
How Noveltreat compares
| Brand | Company | Approved for (at launch) | MRP per month |
|---|---|---|---|
| Semasize | Indian generic | Type 2 diabetes and weight management | ₹1,500 to ₹3,500 |
| Noveltreat | Sun Pharma | Weight management | about ₹3,600 to ₹8,000 at launch |
| Obeda | Dr Reddy's | Type 2 diabetes | about ₹4,200 at launch |
| Poviztra | Emcure (Novo Nordisk brand) | Weight management | ₹3,999 to ₹8,999 |
| Wegovy | Novo Nordisk | Weight management | ₹5,660 to ₹16,400 |
All of these contain semaglutide. The differences are the device, the price and, importantly, what each product is approved for. A product approved only for diabetes isn't licensed for weight management, even though the medicine is the same.
Getting Noveltreat safely
- Buy only with a prescription, from a licensed pharmacy. Never from social media sellers, gyms or salons.
- Check the pack is sealed, the batch number and expiry date are printed clearly, and the price is not far below MRP.
- Pens should arrive cold, in insulated packaging.
- If anything looks wrong, don't inject it. Show it to your pharmacist or doctor.
Questions
Is Noveltreat approved for weight loss?
Yes. Sun Pharma's Noveltreat is approved in India for chronic weight management in adults.
What is the price of Noveltreat?
At launch in March 2026, about ₹900 to ₹2,000 a week depending on the dose. Check the current MRP, as prices are changing.
Is Noveltreat the same as Wegovy?
Both contain semaglutide for weight management at the same dose steps. Noveltreat is made by Sun Pharma; Wegovy by Novo Nordisk. The pens and prices differ.
What is Sematrinity?
Sun Pharma's semaglutide brand for type 2 diabetes, in 2 mg and 4 mg multi-dose pens.
References
- Sun Pharma launches semaglutide injection under brand names Noveltreat and Sematrinity, BioSpectrum India, March 2026
- Rs 325 to 4,200 a month: Dr Reddy's, Sun Pharma, Glenmark kick off generic semaglutide price war, ThePrint, March 2026
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
- World Health Organization. WHO issues global guideline on the use of GLP-1 medicines in treating obesity, 1 December 2025
- Indian maximum retail prices checked October 2026
